We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$52B
AUM Growth
-$1.61B
(-3%)
Cap. Flow
-$421M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
764
New
196
Increased
225
Reduced
259
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$109M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$92.2M |
| 3 |
Corning
GLW
|
+$81.5M |
| 4 |
IQVIA
IQV
|
+$62.7M |
| 5 |
Casella Waste Systems
CWST
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$715M |
| 2 |
Starbucks
SBUX
|
+$159M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$97.2M |
| 4 |
American Express
AXP
|
+$92.9M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$53.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.2% |
| 2 | Consumer Discretionary | 17.52% |
| 3 | Financials | 11.75% |
| 4 | Communication Services | 11.63% |
| 5 | Healthcare | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cabot Corp
CBT
$4.52B
| $11.6M | 0.02% |
255,749
-753
| -0.3% | -$32.5K |
|
|
EVBG
302
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $11.5M | 0.02% |
187,094
+64,786
| +53% | +$5.49M |
|
|
PRA
303
DELISTED
ProAssurance
PRA
| $11.5M | 0.02% |
284,618
-786
| -0.3% | -$30.4K |
|
304
Urban Outfitters
URBN
$6.59B
| $11.5M | 0.02% |
407,881
-1,123
| -0.3% | -$26.2K |
|
305
Varex Imaging
VREX
$523M
| $11.5M | 0.02% |
401,418
-1,122
| -0.3% | -$32.5K |
|
|
RAVN
306
DELISTED
Raven Industries Inc
RAVN
| $11.4M | 0.02% |
342,013
-838
| -0.2% | -$28.2K |
|
307
Methode Electronics
MEI
$592M
| $11.4M | 0.02% |
337,414
-978
| -0.3% | -$29.6K |
|
308
Carter's
CRI
$1.47B
| $11.3M | 0.02% |
124,033
+25,100
| +25% | +$2.29M |
|
|
CBM
309
DELISTED
Cambrex Corporation
CBM
| $11.1M | 0.02% |
187,299
-202,351
| -52% | -$10.8M |
|
|
CADE
310
DELISTED
Cadence Bank
CADE
| $11.1M | 0.02% |
373,336
-83,306
| -18% | -$2.38M |
|
|
PACW
311
DELISTED
PacWest Bancorp
PACW
| $11M | 0.02% |
303,484
-904
| -0.3% | -$32.7K |
|
312
Pathward Financial
CASH
$1.8B
| $10.9M | 0.02% |
334,707
-916
| -0.3% | -$27.6K |
|
313
AdvanSix
ASIX
$444M
| $10.9M | 0.02% |
423,656
-36,461
| -8% | -$887K |
|
314
Woodward
WWD
$21.4B
| $10.9M | 0.02% |
+100,660
| New | +$11.1M |
|
315
Cathay General Bancorp
CATY
$4.24B
| $10.8M | 0.02% |
312,229
-65,836
| -17% | -$2.3M |
|
316
Charles River Laboratories
CRL
$12.8B
| $10.8M | 0.02% |
+81,491
| New | +$10.9M |
|
317
Amphenol
APH
$209B
| $10.7M | 0.02% |
445,208
+2,812
| +0.6% | +$64.8K |
|
318
OceanFirst Financial
OCFC
$1.91B
| $10.7M | 0.02% |
452,946
-1,120
| -0.2% | -$26.1K |
|
319
Wyndham Hotels & Resorts
WH
$5.48B
| $10.7M | 0.02% |
205,931
+129
| +0.1% | +$7.05K |
|
320
Jazz Pharmaceuticals
JAZZ
$16.7B
| $10.6M | 0.02% |
82,839
+15,947
| +24% | +$2.14M |
|
321
McGrath RentCorp
MGRC
$2.92B
| $10.4M | 0.02% |
+149,315
| New | +$9.8M |
|
322
NNN REIT
NNN
$8.99B
| $10.3M | 0.02% |
182,844
-535
| -0.3% | -$29.1K |
|
323
Viavi Solutions
VIAV
$9.66B
| $10.2M | 0.02% |
729,714
-1,659
| -0.2% | -$23.6K |
|
324
Ultragenyx Pharmaceutical
RARE
$2.55B
| $10.2M | 0.02% |
238,194
+18,940
| +9% | +$1.03M |
|
325
Cemex
CX
$16.3B
| $10.1M | 0.02% |
2,587,181
-58,901
| -2% | -$216K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2019 Portfolio in Review
As of Q3 2019, Loomis, Sayles & Company held 764 positions worth $52B, down 3% from $53.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q3 2019 filing shows 196 new, 225 increased, 259 reduced and 63 closed positions. Its largest new stake was IQVIA: 402,725 shares worth $60.2M. The largest sale was Bank of America Series L, an estimated $715M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q3 2019 buy was IQVIA: 402,725 shares worth $60.2M.
- Loomis, Sayles & Company added most to Monster Beverage in Q3 2019, an estimated $109M increase.
- Loomis, Sayles & Company's biggest Q3 2019 reduction was Bank of America Series L, cutting an estimated $715M.
- Loomis, Sayles & Company fully exited Wright Medical Group Inc in Q3 2019, selling an estimated $53.7M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $52B portfolio in Q3 2019.
- Loomis, Sayles & Company opened 196 new positions and closed 63 in Q3 2019.
- Loomis, Sayles & Company's portfolio value fell 3% quarter-over-quarter to $52B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2019, filed 13 Nov 2019.